Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine/Lidocaine Mesotherapy for Neuropathic Pain in CRPS1
NCT04650074Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Nov 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in Complex Regional Pain Syndrome Type 1 (CRPS-1), neuropathic pain, sponsored by Hospices Civils de Lyon. Started Nov 2021; status: completed.
02
Drugs
ketamine
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)neuropathic pain
Beyond the preview
Go deeper on NCT04650074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04650074.